Company news
Sinovac Biotech, Ltd. news in 2021
Sinovac Biotech, Ltd.'s news releases, calls and decks from 2021, newest first.
SINOVAC Reports Unaudited First Half of 2021 Financial Results
December 29, 2021
Antigua Court of Appeal Rules in Favor of SINOVAC, Upholds 2018 Judgment
December 8, 2021
SINOVAC Beijing Settled Litigation of Its Business License and Seals
December 2, 2021
Preliminary Results Show SINOVAC’s COVID-19 Vaccine Demonstrates Good Safety Profile Among the Pediatric and Adolescent Population
November 8, 2021
New Research on SINOVAC’s COVID-19 Vaccine Shows Third Dose More Effective Against COVID-19, Including the Delta Variant
September 8, 2021
SINOVAC Announces COVID-19 Vaccine Approved for Emergency Use in Chile for Children and Adolescents
September 7, 2021
SINOVAC Announces Positive Data on Booster Shots of CoronaVac®, Induces Strong Immune Response in Adult and Elderly Populations
August 9, 2021
SINOVAC Receives Approval on Sabin Strain Based Inactivated Polio Vaccine (sIPV) to Support Global Polio Endgame Strategy
July 18, 2021
SINOVAC Enters Into Agreement to Supply CoronaVac® to COVAX
July 11, 2021
The Lancet Infectious Diseases Published Data from Sinovac’s Phase I/II Study, World’s First Published Study on Clinical Trial Results of a COVID-19 Vaccine in Healthy Children and Adolescents Aged 3 to 17 Years Old
June 29, 2021
World Health Organization Authorizes SINOVAC’s CoronaVac® for Emergency Use
June 1, 2021
Sinovac Reports Unaudited Fourth Quarter 2020 Financial Results and Files 2020 Annual Report on Form 20-F
April 21, 2021
Sinovac Announced Buildup of Two Billion Annual Capacity of Its COVID-19 Vaccine
March 31, 2021
Sinovac Receives Conditional Marketing Authorization in China for its COVID-19 Vaccine
February 7, 2021
Sinovac Announces Phase III Results of Its COVID-19 Vaccine
February 4, 2021
Sinovac Files for Conditional Market Authorization of COVID-19 Vaccine in China
February 2, 2021